Journal of Clinical Endocrinology & Metabolism, Vol 65, 634-642, Copyright © 1987 by Endocrine Society

ARTICLES

Free fatty acids block growth hormone (GH) releasing hormone-stimulated GH secretion in man directly at the pituitary

FF Casanueva, L Villanueva, C Dieguez, Y Diaz, JA Cabranes, B Szoke, MF Scanlon, AV Schally and A Fernandez-Cruz
Department of Internal Medicine, Faculty of Medicine, Compostela University, Madrid, Spain.

Increases in plasma FFA levels inhibit GH responses to a variety of pharmacological and physiological stimuli. To gain further insight into the mechanism by which FFA exert their effect, we studied the plasma GH responses to GHRH-(1-44) (1 microgram/kg, iv) in normal subjects in whom plasma FFA levels were raised by a lipid-heparin infusion (250 mL 10% Intralipid plus 2500 U heparin). Paired tests were performed in 10 normal subjects, with and without lipid-heparin pretreatment. Lipid- heparin infusion from -30 to 120 min increased mean FFA levels from 0.41 +/- 0.03 (+/- SEM) to 3.12 +/- 0.40 mmol/L at 120 min. The mean plasma GH levels after GHRH administration were lower at all times; however, the values were significantly different (P less than 0.05) only at the later times (45, 60, and 90 min). When considered individually, an all or none pattern was observed; 5 subjects had no plasma GH response to GHRH, and 5 had no reduction. To investigate the time relationships between the FFA peak and subsequent GH blockade, a different protocol of paired tests was performed with GHRH with or without a different lipid-heparin infusion protocol. Lipid-heparin was infused from -90 to 0 min, with an additional heparin pulse at -15 min, to obtain a higher and earlier (0 min) FFA increase. FFA increased from 1.06 +/- 0.19 to 11.61 +/- 0.83 mmol/L at zero time. The GHRH-induced GH secretory peak (15.8 +/- 3.5 ng/ml) at 15 min was completely blocked (0.9 +/- 0.2 ng/ml), and the mean plasma GH levels were also lower at 30, 45, and 60 min. To determine whether the FFA-induced blockade of GH secretion was exerted in the pituitary, a series of in vitro studies was conducted using monolayer cultures of rat anterior pituitary glands, with GHRH concentrations of both 10(-10) and 10(-8) M and 10(- 5) M forskolin to stimulate GH release. Both caprylic and oleic acid inhibited basal GH release and GHRH- or forskolin-induced GH release. PRL release was not altered, nor were toxic actions noted on the cells. In conclusion, FFA are able to block GH secretion directly at the pituitary level.

This article has been cited by other articles:

				K. A. Stokes, C. Tyler, and K. L. Gilbert The growth hormone response to repeated bouts of sprint exercise with and without suppression of lipolysis in men J Appl Physiol, March 1, 2008; 104(3): 724 - 728. [Abstract] [Full Text] [PDF]

				R. M Luque, M. D Gahete, R. J Valentine, and R. D Kineman Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis. J. Mol. Endocrinol., August 1, 2006; 37(1): 25 - 38. [Abstract] [Full Text] [PDF]

				C. Franco, J. D Veldhuis, A. Iranmanesh, J. Brandberg, L. Lonn, B. Andersson, B.-A. Bengtsson, J. Svensson, and G. Johannsson Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity. Eur. J. Endocrinol., August 1, 2006; 155(2): 261 - 268. [Abstract] [Full Text] [PDF]

				F. Lanfranco, L. Gianotti, A. Picu, R. Giordano, G. A. Daga, V. Mondelli, G. Malfi, S. Fassino, E. Ghigo, and E. Arvat Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa. Eur. J. Endocrinol., May 1, 2006; 154(5): 731 - 738. [Abstract] [Full Text] [PDF]

				K. Stokes, M. Nevill, J. Frystyk, H. Lakomy, and G. Hall Human growth hormone responses to repeated bouts of sprint exercise with different recovery periods between bouts J Appl Physiol, October 1, 2005; 99(4): 1254 - 1261. [Abstract] [Full Text] [PDF]

				D. Glintborg, R. K. Stoving, C. Hagen, A. P. Hermann, J. Frystyk, J. D. Veldhuis, A. Flyvbjerg, and M. Andersen Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5605 - 5612. [Abstract] [Full Text] [PDF]

				S. V Haijma, P S. van Dam, W. R de Vries, I. Maitimu-Smeele, C. Dieguez, F. F Casanueva, and H. P F Koppeschaar The GHRH/GHRP-6 test for the diagnosis of GH deficiency in elderly or severely obese men Eur. J. Endocrinol., April 1, 2005; 152(4): 575 - 580. [Abstract] [Full Text] [PDF]

				X.-D. Qu, I. T. Gaw Gonzalo, M. Y. Al Sayed, P. Cohan, P. D. Christenson, R. S. Swerdloff, D. F. Kelly, and C. Wang Influence of Body Mass Index and Gender on Growth Hormone (GH) Responses to GH-Releasing Hormone Plus Arginine and Insulin Tolerance Tests J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1563 - 1569. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF]

				P. Kok, M. M. Buijs, S. W. Kok, I. H. A. P. van Ierssel, M. Frolich, F. Roelfsema, P. J. Voshol, A. E. Meinders, and H. Pijl Acipimox enhances spontaneous growth hormone secretion in obese women Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2004; 286(4): R693 - R698. [Abstract] [Full Text] [PDF]

				F. Lanfranco, R. Giordano, M. Pellegrino, L. Gianotti, J. Ramunni, A. Picu, M. Baldi, E. Ghigo, and E. Arvat Free Fatty Acids Exert an Inhibitory Effect on Adrenocorticotropin and Cortisol Secretion in Humans J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1385 - 1390. [Abstract] [Full Text] [PDF]

				K. Hussain, P. Hindmarsh, and A. Aynsley-Green Spontaneous Hypoglycemia in Childhood Is Accompanied by Paradoxically Low Serum Growth Hormone and Appropriate Cortisol Counterregulatory Hormonal Responses J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3715 - 3723. [Abstract] [Full Text] [PDF]

				J. M. Miles, D. Wooldridge, W. J. Grellner, S. Windsor, W. L. Isley, S. Klein, and W. S. Harris Nocturnal and Postprandial Free Fatty Acid Kinetics in Normal and Type 2 Diabetic Subjects: Effects of Insulin Sensitization Therapy Diabetes, March 1, 2003; 52(3): 675 - 681. [Abstract] [Full Text] [PDF]

				K. A. Stokes, M. E. Nevill, G. M. Hall, and H. K. A. Lakomy Growth hormone responses to repeated maximal cycle ergometer exercise at different pedaling rates J Appl Physiol, February 1, 2002; 92(2): 602 - 608. [Abstract] [Full Text] [PDF]

				M. Ciampelli, G. Muzj, F. Leoni, D. Romualdi, C. Belosi, R. M. Cento, and A. Lanzone Metabolic and Endocrine Consequences of Acute Suppression of FFAs by Acipimox in Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5324 - 5329. [Abstract] [Full Text] [PDF]

				P. Sytze van Dam, H. E. C. Smid, W. R. de Vries, M. Niesink, E. Bolscher, E. J. Waasdorp, C. Dieguez, F. F. Casanueva, and H. P. F. Koppeschaar Reduction of Free Fatty Acids By Acipimox Enhances the Growth Hormone (GH) Responses to GH-Releasing Peptide 2 in Elderly Men J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4706 - 4711. [Abstract] [Full Text]

				Y. Hashimoto, T. Kamioka, M. Hosaka, K. Mabuchi, A. Mizuchi, Y. Shimazaki, M. Tsunoo, and T. Tanaka Exogenous 20K Growth Hormone (GH) Suppresses Endogenous 22K GH Secretion in Normal Men J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 601 - 606. [Abstract] [Full Text]

				R. Lanzi, M. Losa, G. Mignogna, A. Caumo, and A. E. Pontiroli The Control on Growth Hormone Release by Free Fatty Acids Is Maintained in Acromegaly J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1234 - 1238. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, D. Bilinski, A. Giacca, and M. Vranic Counterregulatory Response to Hypoglycemia Differs According to the Insulin Delivery Route, But Does Not Affect Glucose Production in Normal Humans J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1037 - 1046. [Abstract] [Full Text]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				N. Briard, M. Rico-Gomez, V. Guillaume, N. Sauze, V. Vuaroqueaux, F. Dadoun, Y. Le Bouc, C. Oliver, and A. Dutour Hypothalamic Mediated Action of Free Fatty Acid on Growth Hormone Secretion in Sheep Endocrinology, December 1, 1998; 139(12): 4811 - 4819. [Abstract] [Full Text] [PDF]

				X. Casabiell, V. Piñeiro, R. Peino, M. Lage, J. Camiña, R. Gallego, L. G. Vallejo, C. Dieguez, and F. F. Casanueva Gender Differences in Both Spontaneous and Stimulated Leptin Secretion by Human Omental Adipose Tissue in Vitro: Dexamethasone and Estradiol Stimulate Leptin Release in Women, But Not in Men J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2149 - 2155. [Abstract] [Full Text]

				A. Leal-Cerro, L. M. Jimenez, R. Astorga, I. Fernandez-Lopez, C. Dieguez, and F. F. Casanueva Acute Pharmacological Reduction of Plasma Free Fatty Acids Enhances the Growth Hormone (GH)-Releasing Hormone-Mediated GH Secretion in Patients with Cushing's Syndrome J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3165 - 3168. [Abstract] [Full Text] [PDF]

				R. Lanzi, M. F. Manzoni, A. C. Andreotti, M. E. Malighetti, E. Bianchi, L. P. Sereni, A. Caumo, L. Luzi, and A. E. Pontiroli Evidence for an Inhibitory Effect of Physiological Levels of Insulin on the Growth Hormone (GH) Response to GH-Releasing Hormone in Healthy Subjects J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2239 - 2243. [Abstract] [Full Text] [PDF]

				C. A. M. Roelen, H. P. F. Koppeschaar, W. R. de Vries, Y. E. M. Snel, M. E. Doerga, P. M. J. Zelissen, J. H. H. Thijssen, and M. A. Blankenstein Visceral Adipose Tissue Is Associated with Circulating High Affinity Growth Hormone-Binding Protein J. Clin. Endocrinol. Metab., March 1, 1997; 82(3): 760 - 764. [Abstract] [Full Text] [PDF]

				F. R. Perez, X. Casabiell, J. P. Camina, J. L. Zugaza, and F. F. Casanueva cis-Unsaturated Free Fatty Acids Block Growth Hormone and Prolactin Secretion in Thyrotropin-Releasing Hormone-Stimulated GH3 Cells by Perturbing the Function of Plasma Membrane Integral Proteins Endocrinology, January 1, 1997; 138(1): 264 - 272. [Abstract] [Full Text] [PDF]